pharmaphorum

JANUARY 3, 2023

Ben Hargreaves examines why there is no easy answer to the question of when palliative care is the right option for patients. However, the authors concluded that the emergence of such treatments had led to “the tendency to use immunotherapy in EOL (end-of-life) settings where less aggressive approaches may be preferable.”

Healthcare 96

Healthcare Healthcare Patients Side effects 96

pharmaphorum

NOVEMBER 28, 2022

With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact. The authors outline that the process “is no different from a business’s commercial agenda. The past eight years are set to be the eight warmest on record.

Pharma 97

Pharma Consulting Education Management 97

pharmaphorum

JUNE 28, 2022

In the first of a three part series, Ben Hargreaves looks at what the odds are of another pandemic arising in our lifetimes and what can be done to lower the risk of this happening again. The authors suggest that even a 1% reduction in risk of viral zoonotic disease emergence would make any efforts in this direction cost-effective.

Government 52

Government Medical Pharma Training 52

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics.

Distribution 73

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 73

pharmaphorum

NOVEMBER 16, 2022

However, alongside this progress, Ben Hargreaves finds that there is also a conundrum over how to price these therapies. The authors write that the majority of the world is excluded from the benefits of modern medicine, and called for greater effort to cater research and financing for low- to middle-income countries.

Medicine 123

Medicine Marketing Healthcare Healthcare 123

pharmaphorum

JANUARY 30, 2023

Ben Hargreaves examines why these shortages are happening and what is being done in the background to return supply to normal. Across the world, there are reports of shortages of common antibiotics. In many countries across the world, there are shortages of common antibiotics.

Food and Drug Administration 82

Food and Drug Administration Medicine Manufacturing Pharmaceutical 82

pharmaphorum

OCTOBER 4, 2022

In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot. The author of the study noted that researchers from anywhere in the world can now request access to the growing dataset that is being generated by the Biobank effort. Up in the clouds.

Electronics 91

Electronics Patients Management Insurance 91